Information:
Error:
ID
23231
Description
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00412997
Link
https://clinicaltrials.gov/show/NCT00412997
Keywords
Versions (1)
- 6/29/17 6/29/17 -
Uploaded on
June 29, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Tumors NCT00412997
Eligibility Tumors NCT00412997
- StudyEvent: Eligibility
Similar models
Eligibility Tumors NCT00412997
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Standard therapy Solid tumour Advanced | Disease Progression | Standard therapy Lacking | Standard therapy Cutaneous T-Cell Lymphoma | Disease Progression | Standard therapy Lacking
Item
patients with either a) histologically-confirmed, advanced solid tumors whose disease has progressed despite standard therapy or for whom no standard therapy exists, or b) cytopathologically confirmed cutaneous t-cell lymphoma (ctcl) whose disease has progressed despite standard therapy or for whom no standard therapy exists. inclusion is irrespective of stage of disease or extent of prior therapy.
boolean
C2936643 (UMLS CUI [1,1])
C0280100 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C2936643 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0079773 (UMLS CUI [4,2])
C0242656 (UMLS CUI [5])
C2936643 (UMLS CUI [6,1])
C0332268 (UMLS CUI [6,2])
C0280100 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C2936643 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0079773 (UMLS CUI [4,2])
C0242656 (UMLS CUI [5])
C2936643 (UMLS CUI [6,1])
C0332268 (UMLS CUI [6,2])
WHO performance status scale
Item
world health organization (who) performance status of ≤ 2
boolean
C1298650 (UMLS CUI [1])
Laboratory Results
Item
patients must have the adequate laboratory values
boolean
C1254595 (UMLS CUI [1])
Central Nervous System Neoplasms, Primary
Item
patients with a history of primary cns tumors
boolean
C0751620 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
patients with any history of brain metastases
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy CTCAE Grades
Item
patients with any peripheral neuropathy ≥ ctcae grade 2
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Diarrhea Unresolved CTCAE Grades
Item
patients with unresolved diarrhea ≥ ctcae grade 2
boolean
C0011991 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Decreased cardiac function
Item
impairment of cardiac function
boolean
C0232166 (UMLS CUI [1])
Gastrointestinal function Impairment | Gastrointestinal Diseases
Item
impairment of gastrointestinal (gi) function or gi disease
boolean
C0516983 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
C0221099 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0022658 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])